Search

everythinglearnresearchcommunity

for

Search:↓

Male-pattern baldness has a weak link to heart disease and some related health conditions.

Baldness caused by male hormones in female-to-male transsexuals doesn't increase the risk of heart disease.

Women with PCOS in Sicily show different levels of metabolic problems depending on their PCOS type, with obesity and abnormal lipid profiles being common.

Women with female pattern hair loss may have a higher risk of metabolic syndrome.

South Asian women with PCOS are more likely to have metabolic issues and central obesity, and simple measures like waist size and blood pressure can help identify these risks early.

Severe insulin resistance can be managed with medication, lifestyle changes, and treatment for related conditions.

Non-obese women with hair loss have higher heart disease risk.

Blocking a specific enzyme might help treat obesity and diabetes, but more research is needed to ensure it's safe.

Women with PCOS are more likely to have fatty liver disease and worse metabolic health.

Many young Australian women think they have PCOS, but only a few are diagnosed correctly, causing unnecessary worry.

The document concludes that Rabson-Mendenhall syndrome requires novel treatments for insulin resistance and emphasizes the importance of dental care in affected patients.

High levels of male hormones in women without tumors are linked to metabolic problems and can be treated with metformin.

Taking 5α-reductase inhibitors with prednisolone can worsen its negative effects on metabolism.

The document explains the difficulty in diagnosing and treating brain diseases caused by the immune system and stresses the need for quick and accurate tests.

High Lipid Accumulation Product levels are linked to more hirsutism in women with Polycystic Ovary Syndrome.

A 5-year-old Akita with a rare skin condition improved significantly after treatment.

Tacrolimus causes fewer acute rejections than cyclosporin A in kidney transplants but doesn't necessarily improve kidney function after one year; cardiovascular risks and side effects vary between the two drugs.

Cyproterone acetate therapy improved hair loss and reduced testosterone levels in a menopausal woman.

About 19.4% of Iranian women in the study have Polycystic Ovary Syndrome, with the most common type involving irregular periods and high male hormone levels, but their heart and metabolic health is similar to women without the condition.

Low vitamin D levels may affect ovulation and progesterone in infertile women.

Genetic risk for PCOS can affect children's growth, metabolism, and development from early life into adulthood.

Lifestyle changes can improve body composition, excess male hormone levels, and insulin resistance in women with PCOS.

The guidelines suggest lifestyle changes, diet adjustments, and personalized medication to manage dyslipidemia and reduce heart disease risk.

Metformin helps with menstrual cycles and insulin levels in PCOS but is less effective for hair growth, diabetes prevention, and weight loss, and may improve fertility and reduce diabetes risk.

Greek women with PCOS have a higher risk of metabolic syndrome and are more likely to be overweight compared to healthy controls.

Metabolic syndrome in kids and teens is linked to obesity and increases diabetes and heart disease risk; early lifestyle changes are crucial for management.

Insulin resistance is common in PCOS patients and linked to obesity and increased cardiovascular risk.

PCOS symptoms change with age; younger women have higher androgen levels and less metabolic issues, while older women face more metabolic challenges despite milder PCOS symptoms.

Early balding linked to higher heart disease risk.

Glucocorticoids are powerful anti-inflammatory drugs that must be used carefully to avoid serious side effects.